首页 | 本学科首页   官方微博 | 高级检索  
     

β射线局部照射对冠状动脉弥漫性支架内再狭窄的疗效
引用本文:周颖玲,黄文晖,罗建方,李光,谭宁,李瑜辉,陈纪言. β射线局部照射对冠状动脉弥漫性支架内再狭窄的疗效[J]. 中华核医学杂志, 2004, 24(4): 232-233
作者姓名:周颖玲  黄文晖  罗建方  李光  谭宁  李瑜辉  陈纪言
作者单位:510100,广州,广东省人民医院、广东省心血管病研究所心内科
摘    要:目的:探讨β射线(^90Sr/^90Y)对冠状动脉(简称冠脉)弥漫性支架内再狭窄的疗效。方法:39例经皮冠脉介入术(PCI)及支架置入术后支架内再狭窄患者,随机分为支架内放射治疗组(治疗组)18例及单纯球囊组(对照组)21例。2组患者再狭窄病变先经充分球囊扩张,治疗组用Beta-Cath系统进行冠脉内放射治疗。术后随访9个月。结果:治疗组1例(5.6%)研究段血管再狭窄,对照组有8例(38.1%)再狭窄,两组间差异有显著性(P=0.006)。结论:β射线治疗冠脉弥漫性支架内再狭窄安全、有效、可行。

关 键 词:支架内再狭窄 弥漫性 冠脉 治疗组 β射线 冠状动脉 局部照射 结论 显著性 目的

Clinical effects of intracoronary brachytherapy on diffuse in-stent restenosis after coronary angioplasty
ZHOU Ying-ling,HUANG Wen-hui,LUO Jian-fang,et al.. Clinical effects of intracoronary brachytherapy on diffuse in-stent restenosis after coronary angioplasty[J]. Chinese Journal of Nuclear Medicine, 2004, 24(4): 232-233
Authors:ZHOU Ying-ling  HUANG Wen-hui  LUO Jian-fang  et al.
Affiliation:ZHOU Ying-ling,HUANG Wen-hui,LUO Jian-fang,et al. Department of Cardiology,Guangdong Provincial Cardiovascular Institute,Guangzhou 510100,China Corresponding author: Chen Ji-yan
Abstract:Objective To investigate the effect of intracoronary brachytherapy using 90 Sr/ 90 Y on in-stent restenosis in patients with coronary disease. Methods Thirty-nine patients (male 29 ,female 10) with in-stent restenosis after percutaneous coronary intervention (PCI) were studied. The patients were divided randomly into two groups: single-balloon group(21 cases,control group) and brachytherapy group(18 cases,treatment group). All the lesions were treated with balloon angioplasty satisfactorily. After that the patients in treatment group took a brachytherapy using the Beta-Cath system(Novoste). After the operation,there was a 9-months follow-up. Results Within the follow-up,one case (5.6%) in treatment group was found to be with in-stent restenosis and 8 cases(38.1%) in control group. There was significant difference between the two groups(P=0.006). Conclusion The brachytherapy using 90 Sr/ 90 Y after balloon angioplasty is safe,effective and feasible for containing diffuse in-stent restenosis in patients.
Keywords:Coronary disease  Stents  Hyperplasia  Brachytherapy  Strontium radioisotopes  Yttrium radioisotopes
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号